Richard Dodel

21.6k total citations · 1 hit paper
289 papers, 11.9k citations indexed

About

Richard Dodel is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Richard Dodel has authored 289 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Neurology, 65 papers in Physiology and 62 papers in Psychiatry and Mental health. Recurrent topics in Richard Dodel's work include Parkinson's Disease Mechanisms and Treatments (118 papers), Alzheimer's disease research and treatments (59 papers) and Neurological disorders and treatments (54 papers). Richard Dodel is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (118 papers), Alzheimer's disease research and treatments (59 papers) and Neurological disorders and treatments (54 papers). Richard Dodel collaborates with scholars based in Germany, United States and United Kingdom. Richard Dodel's co-authors include Yansheng Du, Wolfgang H. Oertel, Wolfgang H. Oertel, Annika Spottke, Uwe Siebert, Jens Peter Reese, Michael Bacher, Monika Balzer‐Geldsetzer, Martin R. Farlow and Kelly R. Bales and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Richard Dodel

278 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

2001 655 citations Yansheng Du, Zhizhong Ma et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Richard Dodel

Since Specialization

Citations

This map shows the geographic impact of Richard Dodel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Dodel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Dodel more than expected).

Fields of papers citing papers by Richard Dodel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Dodel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Dodel. The network helps show where Richard Dodel may publish in the future.

Co-authorship network of co-authors of Richard Dodel

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Dodel. A scholar is included among the top collaborators of Richard Dodel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Dodel. Richard Dodel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity 2025 ·Journal of Autoimmunity ·Carmen Noelker, Florian Seitz, (unknown), Frauke Neff, (unknown), (unknown), Armin Geyer, (unknown), Michael Bacher, Richard Dodel	0
2	A network perspective on cognition in individuals with Parkinson's disease 2025 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·(unknown), Elke Kalbe, Monika Balzer‐Geldsetzer, Daniela Berg, (unknown), Jan Kassubek, Inga Liepelt‐Scarfone, Brit Mollenhauer, Kathrin Reetz, Oliver Riedel, Sandra Roeske, Jörg B. Schulz, Alexander Storch, Claudia Trenkwalder, Karsten Witt, Hans‐Ulrich Wïttchen, Richard Dodel, Anja Ophey	0
3	Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns 2024 ·Journal of Neuroinflammation ·(unknown), (unknown), Anja Hviid Simonsen, (unknown), (unknown), Kristian Winge, Lisette Salvesen, Sára Bech, Anne‐Mette Hejl, Annemette Løkkegaard, Steen Gregers Hasselbalch, Richard Dodel, Susana Aznar, Gunhild Waldemar, Tomasz Brudek, Jonas Folke	0
4	Systematic review-based guideline “Parkinson’s disease” of the German Society of Neurology: diagnostic use of transcranial sonography 2024 ·Journal of Neurology ·Uwe Walter, (unknown), Richard Dodel, Alexander Storch, Claudia Trenkwalder, Günter U. Höglinger, (unknown)	4
5	Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson’s disease: cross-sectional and longitudinal evidence from the LANDSCAPE study 2024 ·Journal of Neurology ·Anja Ophey, (unknown), Steffen Wolfsgruber, Monika Balzer‐Geldsetzer, Daniela Berg, (unknown), Jan Kassubek, Inga Liepelt‐Scarfone, Sara Becker, (unknown), Kathrin Reetz, Oliver Riedel, Jörg B. Schulz, Alexander Storch, Claudia Trenkwalder, Karsten Witt, Hans‐Ulrich Wïttchen, Richard Dodel, Sandra Roeske, Elke Kalbe	4
6	Parkinson-Krankheit und Demenz vom Alzheimer-Typ – Pathophysiologie und medikamentöse Therapieansätze 2023 ·Die Innere Medizin ·Richard Dodel	1
7	Meaning in Life in Late-Stage Parkinson’s Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries 2023 ·Journal of Religion and Health ·(unknown), (unknown), Martin Fegg, Joaquim J. Ferreira, Per Odin, Bastiaan R. Bloem, Wassilios G. Meissner, Richard Dodel, Anette Schrag, Stefan Lorenzl	1
8	A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study 2021 ·Parkinsonism & Related Disorders ·(unknown), Anja Ophey, Jörg B. Schulz, Kathrin Reetz, (unknown), Alexander Storch, Inga Liepelt‐Scarfone, Sara Becker, Daniela Berg, Monika Balzer‐Geldsetzer, Jan Kassubek, (unknown), Karsten Witt, Brit Mollenhauer, Claudia Trenkwalder, Sandra Roeske, Hans‐Ulrich Wïttchen, Oliver Riedel, Richard Dodel, Elke Kalbe	10
9	Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease 2021 ·Neurobiology of Aging ·Daniel Charissé, Güray Erus, Raymond Pomponio, Martin Gorges, Nele Schmidt, Christine Schneider, Inga Liepelt‐Scarfone, Oliver Riedel, Kathrin Reetz, Jörg B. Schulz, Daniela Berg, Alexander Storch, Karsten Witt, Richard Dodel, Elke Kalbe, Jan Kassubek, (unknown), Simon Baudrexel	19
10	Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study 2019 ·Therapeutic Advances in Neurological Disorders ·Martin Gorges, Hans‐Peter Müller, Inga Liepelt‐Scarfone, Alexander Storch, Richard Dodel, (unknown), Daniela Berg, Martin Kunz, Elke Kalbe, Simon Baudrexel, Jan Kassubek	19
11	Quality of life in a German cohort of Parkinson’s patients assessed with three different measures 2018 ·Journal of Neurology ·Monika Balzer‐Geldsetzer, Jens Klotsche, Richard Dodel, Oliver Riedel	23
12	Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study 2018 ·BMC Neurology ·Monika Balzer‐Geldsetzer, Joaquim J. Ferreira, Per Odin, Bastiaan R. Bloem, Wassilios G. Meissner, Stefan Lorenzl, Michael Wittenberg, Richard Dodel, Anette Schrag	26
13	Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study 2015 ·Value in Health ·Mark Belger, (unknown), Richard Dodel, Josep María Haro, Anders Wimo, Catherine Reed	4
14	An application of electronic nose technology for diagnosis of Alzheimer's disease 2013 ·European Respiratory Journal ·Andreas Rembert Koczulla, Maike Gold, Akira Hattesohl, (unknown), David Mengel, Severin Schmid, Björn Tackenberg, Jürgen Rieke, Sasidhar Maddula, Jan Baumbach, (unknown), Judith Alferink, Michael T. Heneka, Wolfgang H. Oertel, Frank Jessen, Sabina Janciauskiene, Claus Vogelmeier, Richard Dodel, Jan‐Philipp Bach	1
15	Economic Evaluation of Treatment Options in Patients with Alzheimerʼs Disease 2012 ·Drugs ·(unknown), Judith Dams, Jürgen Wasem, Richard Dodel, Anja Neumann	61
16	QL2 Evaluation of Minimal Clinically Important Differences for Health-Related Quality of Life Scales in Parkinson'S Disease 2012 ·Value in Health ·Yaroslav Winter, (unknown), Wolfgang H. Oertel, Richard Dodel	5
17	Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease 2011 ·PMC ·Richard Dodel, B. Karthikeyan, Kathy Keyvani, Oliver Deuster, Frauke Neff, (unknown), (unknown), Carsten Stüer, Yousef Al‐Abed, Carmen Noelker, Monika Balzer‐Geldsetzer, Wolfgang H. Oertel, Yansheng Du, Michael Bacher	42
18	Resource Utilization and Costs of Stroke Unit Care in Germany 2004 ·Value in Health ·Richard Dodel, (unknown), (unknown), Sven‐Christian Pawelzik, Annika Spottke, (unknown), Uwe Siebert, Wolfgang H. Oertel, Oliver Schöffski, Tobias Back	66
19	Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease breakdown → 2001 ·Proceedings of the National Academy of Sciences ·Yansheng Du, Zhizhong Ma, Suizhen Lin, Richard Dodel, Feng Gao, Kelly R. Bales, (unknown), Eyassu Chernet, Ken Perry, David L. Nelson, (unknown), Lee A. Phebus, Frank P. Bymaster, Steven M. Paul	655
20	[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy]. 1996 ·PubMed ·Richard Dodel, (unknown), R Köhne-Volland, Thomas D. Szucs, Konrad J. Werhahn, Soheyl Noachtar, WH Oertel	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact